Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It is set to intensify competition with rival Eli Lilly, whose popular weight-loss treatment also got the green light months ago but has yet to go on sale in the world’s second largest pharmaceutical market.

tag:reuters.com,2024:binary_RC2KH6AP3DO6-BASEIMAGE

Reuters

United Kingdom

Novo Nordisk launches obesity drug Wegovy in China

https://www.bbc.com/news/articles/c7487y7x0vwo Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June.It is set to intensify competition with rival Eli Lilly, whose popular weight-loss treatment also got the green light months ago but has yet to go on sale in the world’s second largest pharmaceutical market.More than 180 million… Source

Ad Fontes Media

All Sides

Media Bias/Fact Check

BBC News

Government of the United Kingdom

Popular weight-loss drug Wegovy goes on sale in China

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

The Woodbridge Company

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

United States

Weight-loss drug Wegovy launched in China

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in unlocking a big, fast-growing market for its blockbuster franchise.

Bloomberg

Michael Bloomberg

The Vanguard Group

Howard Buffett

BlackRock

Novo Nordisk Launches Wegovy in China With Prices Well Below US

Several hundred million Chinese could be potential recipients of Novo's weight loss medicine Wegovy.

Flere hundrede millioner kinesere kan v�re potentielle modtagere af Novos v�gttabsmedicin Wegovy.

Novo Nordisk lancerer Wegovy i Kina

Politiken

Copenhagen

Denmark

Novo Nordisk launches Wegovy in China

Prices vary by dosage, but a one-month supply of the 0.25 mg starter dose will cost 1,400 yuan ($193.31). That’s lower than the $1,349 in the U.S.

Fortune

Chatchaval Jiaravanon

New York

Novo Nordisk launches Wegovy in China with prices well below U.S.

Novo Nordisk gained approval for Wegovy in China in June, and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug

Firstpost News

Mukesh Ambani

Mumbai

Maharashtra

India

Wegovy in China: Novo Nordisk launches weight-loss drug at cheaper price, eyes 180 mn people with obesity

As US struggles to afford GLP-1 drugs, the rest of the world sees much lower prices.

Ars Technica

Advance Publications

Novo Nordisk sells hit weight-loss drug in China—at fraction of US price

It was really only a matter of time before the Chinese also got access to Novo Nordisk's weight loss drug Wegovy. At the end of June, the Chinese authorities approved the drug, and now the Danish

Det var egentlig kun et spørgsmål om tid, før kineserne også fik adgang til Novo Nordisks vægttabsmiddel Wegovy.I slutningen af juni godkendte de kinesiske myndigheder lægemidlet, og nu har den danske

Så blev det kinesernes tur: Novo lancerer Wegovy i Kina

borsen.dk

Then it was the turn of the Chinese: Novo launches Wegovy in China

The Danish pharmaceutical giant Novo Nordisk is now launching their popular weight loss product, Wegovy, on the Chinese market.

Den danske medicinalgigant Novo Nordisk lancerer nu deres populære vægttabsmiddel, Wegovy, på det kinesiske marked.

Popular weight-loss drug Wegovy goes on sale in China

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics